Farther Finance Advisors, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1992825 SAN FRANCISCO, CA

Position in UTHR

as of Sep 30, 2026 · filed Oct 8, 2026 Compact

Position Value

$383,116

-$327,764 QoQ

Shares Held

707

-46.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 23 holders

Holding Since

Dec 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Sep 30, 2026

Farther Finance Advisors, LLC holds $5,652,044 across 52 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	55,192	$978,002
2	ZTS	Zoetis Inc.	9,999	$698,230
3	HIMS	Hims & Hers Health, Inc.	17,335	$516,409
4	NBIX	Neurocrine Biosciences Inc	3,438	$487,645
5	TAK	Takeda Pharmaceutical Co Ltd	25,420	$462,389
6	UTHR	UNITED THERAPEUTICS Corp This page	707	$383,116
7	COLL	Collegium Pharmaceutical, Inc	16,406	$357,978
8	PBH	Prestige Consumer Healthcare Inc.	7,117	$326,456

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-09-30	$383,116	707	-46.1%	Shares	Sole	2026-10-08
2026-06-30	$710,880	1,312	+60.4%	Shares	Sole	2026-07-17
2026-03-31	$485,057	818	-8.8%	Shares	Sole	2026-04-07
2025-12-31	$437,063	897	+406.8%	Shares	Sole	2026-01-23
2025-09-30	$74,200	177	+149.3%	Shares	Sole	2025-10-14
2025-06-30	$20,401	71	-84.4%	Shares	Sole	2025-07-11
2025-03-31	$140,571	456	+20.3%	Shares	Sole	2025-04-14
2024-12-31	$133,726	379	+6.5%	Shares	Sole	2025-02-10
2024-09-30	$127,572	356	+673.9%	Shares	Sole	2024-10-29
2024-06-30	$14,653	46	+35.3%	Shares	Sole	2024-07-31
2024-03-31	$7,810	34	-45.2%	Shares	Sole	2024-05-14
2023-12-31	$13,633	62	+51.2%	Shares	Sole	2024-02-15
2023-09-30	$9,260	41	-2.4%	Shares	Sole	2023-11-14
2023-06-30	$9,271	42	+20.0%	Shares	Sole	2024-05-14
2023-03-31	$7,838	35	0.0%	Shares	Sole	2024-05-14
2022-12-31	$9,733	35	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.